513 results on '"Tomaniak, Mariusz"'
Search Results
2. The cytokine trio - visfatin, placental growth factor and fractalkine – and their role in myocardial infarction with non-obstructive coronary arteries (MINOCA)
3. Editorial: Reviews in bioresorbable scaffold
4. Zabiegi zamknięcia przetrwałego otworu owalnego i ubytku przegrody międzyprzedsionkowej
5. Przezskórne leczenie wad zastawki trójdzielnej
6. Angiography-Based Fractional Flow Reserve: State of the Art
7. Chemokine Fractalkine and Non-Obstructive Coronary Artery Disease—Is There a Link?
8. A 5-Year Follow-Up Study of 100 Patients with 118 Intermediate Coronary Artery Lesions Evaluated by Fractional Flow Reserve and Intravascular Imaging Stratified According to Renal Function
9. An update on cardiovascular disorders in systemic lupus erythematosus
10. The prognostic value of angiography-based vessel fractional flow reserve after percutaneous coronary intervention: The FAST Outcome study
11. Czynnościowa ocena zmian z analizą mikrokrążenia wieńcowego
12. Angioplastyka wieńcowa w ostrym i przewlekłym zespole wieńcowym
13. Wewnątrzwieńcowe obrazowanie: ultrasonografia wewnątrznaczyniowa (IVUS) i optyczna koherentna tomografia (OCT)
14. Implementation of Microcirculation Examination in Clinical Practice—Insights from the Nationwide POL-MKW Registry
15. Egzamin z kardiologii. Tom 2
16. Egzamin z kardiologii. Tom 3
17. Prognostic Implications of Immature Platelet Fraction at 5-Year Follow-up Among ACS Patients Treated With Dual Antiplatelet Therapy
18. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold
19. Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y12 Inhibitors and Their Association with Platelet Function
20. Immature platelet fraction and immature platelet count as novel biomarkers of elevated platelet reactivity in NSTE-ACS patients receiving dual antiplatelet therapy
21. Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended Survival study
22. Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial
23. Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)
24. Inflammation as a determinant of healing response after coronary stent implantation
25. Endothelial shear stress and vascular remodeling in bioresorbable scaffold and metallic stent
26. Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate Coronary Artery Lesions.
27. Long COVID and its cardiovascular consequences: What is known?
28. The Impact of Coronary Physiology on Contemporary Clinical Decision Making
29. The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial
30. Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS
31. DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI
32. Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study
33. TCT-761 Sirolimus-Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients With ST-Segment Elevation Myocardial Infarction: 18-Month Outcomes: FANTOM STEMI Pilot Study
34. TCT-93 Association Between Post-PCI vFFR and OCT Findings: Results From the FAST OCT Study
35. The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial
36. Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)
37. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease
38. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI
39. Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial
40. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial
41. Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y 12 Inhibitors and Their Association with Platelet Function.
42. In patients with systemic lupus erythematosus and antiphospholipid syndrome renal function is associated with endothelial dysfunction and an NT-proBNP increase: Pilot study.
43. Association between baseline characteristics and clinical outcomes among the elderly undergoing PCI – retrospective cohort study
44. Multimodality OCT, IVUS and FFR evaluation of coronary intermediate grade lesions in women vs. men
45. Intravascular Imaging versus Physiological Assessment versus Biomechanics—Which Is a Better Guide for Coronary Revascularization
46. Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial
47. A serial 3- and 9-year optical coherence tomography assessment of vascular healing response to sirolimus- and paclitaxel-eluting stents
48. Quantitative flow ratio derived from diagnostic coronary angiography in assessment of patients with intermediate coronary stenosis: a wire-free fractional flow reserve study
49. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
50. Out-of-hospital cardiac arrest: Do we have to perform coronary angiography?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.